RankAlpha logo
Back to Rankings

CAI

Caris Life SciencesN/A
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-03
View Chart
+
Peers tracked
8
U.S. public peers
Grade Position
In line
vs peer average
CAI vs peer average
50/100
CAI vs. peer average (N/A vs. B)
Grade spread
A 1 · B 4 · C 2
Graded peers loaded
Coverage
8 graded
100% of tracked

Peer overview

LGND is the first available peer comparator.

Same sector: Pharmaceuticals, Biotechnology & Life Sciences · Cap $4.66B

✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
Top peerLGNDLigand
CAI
Caris Life Sciences
LGND
Ligand
Grade
N/A
B
Momentum
5
72
Value
-
58
Sentiment
-
42
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Unrated
Constructive
Open Side-by-Side ComparisonCompare all

Grade position vs LGND

CAI / LGND
Grade Position
In line
CAI vs. peer average (N/A vs. B)
50/100
Momentum
5
LGND
Value
-
-
Sentiment
-
-

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs CAI
1
LGND
Ligand Pharmaceuticals Inc Common
B
80/100
-
2
NNNN
Anbio Biotechnology Class A Common
N/A
-
-
3
DNTH
Dianthus Therapeutics Inc Common
B
80/100
-
4
CELC
Celcuity Inc Common
A
100/100
-
5
CGON
CG Oncology Inc Common
C
60/100
-
LGND is the first peer returned for this comparison set.